Evidence map›Paper›PMID 42568435›Full record

ArticleFrontiers in oncology2026

Oxygen-enhanced MRI in patients with uterine cervical carcinoma: feasibility and treatment-associated changes in tumour oxygen-enhanced response.

Anubhav Datta, Michael J Dubec, Michael Berks, Ross A Little, Lisa Barraclough, Kate Haslett, Nuria Porta, Prakash Manoharan, David L Buckley, Catharine West and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anubhav DattaDivision of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Michael J DubecDivision of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Michael BerksDivision of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Ross A LittleDivision of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Lisa BarracloughClinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Kate HaslettClinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Nuria PortaClinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom.
Prakash ManoharanClinical Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
David L BuckleyChristie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Catharine WestDivision of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Ananya ChoudhuryDivision of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Peter Hoskin *Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
James P B O'Connor *Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Tumour hypoxia causes resistance against radiotherapy and chemotherapy in locally advanced cervical cancer (LACC). Non-invasive magnetic resonance imaging (MRI) biomarkers have the potential to guide hypoxia-targeted therapy but require technical development and validation. This study evaluated the feasibility and early treatment response monitoring capabilities of oxygen-enhanced MRI (OE-MRI) in healthy female volunteers and patients with LACC. Methods: Healthy volunteers underwent OE-MRI to demonstrate the feasibility of the technique and to compare the onset, magnitude, and duration of change in longitudinal relaxation rate (Δ Results: Feasibility was demonstrated in 97% (31/32) of uterine tissue regions of interest, measured in 18 volunteers. Δ Conclusion: This first dedicated OE-MRI study in cervical cancer shows technique feasibility in healthy volunteers and patients with LACC. Treatment-associated increases in tumour Δ

Indexed as

biomarkercervical cancerhypoxiaMRIradiotherapy

Identifiers

PMID42568435
PMCPMC13447193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.